About Us

Who We Are

Urigen Pharmaceuticals’ leadership is comprised of industry-leading management and world-renowned scientific advisors. Our team has decades of experience in Pharma business, commercial and product development. Collectively, we have planned and executed studies on numerous marketed and development compounds and our management did pioneering work in the field of IC/BPS.

Dan Vickery, PhD, MBA

Director, COO and President Urigen Pharmaceuticals

Dr. Vickery’s experience includes senior corporate business and commercial development positions at Mylan Pharmaceuticals, Inc., and Pharmacia, Inc., and senior regulatory affairs positions at Kabi Pharmacia, Inc., and Warner-Lambert Inc. Dr. Vickery is an advisory board member of the Center for Molecular Medicine and Therapeutics, and on the Board of the Interstitial Cystitis Association.

Lowell Parsons, MD

Chairman and Scientific Founder Urigen Pharmaceuticals

Dr. Parsons is a leader in medical research into the causes and treatment of interstitial cystitis and has published over 200 scientific articles and book chapters in this area describing his work.